4th Quarter - Report
SANDOZ INC for SANDOZ INC
Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Congressional engagement on legislation including but not limited to PBM reform legislation (biosimilars); Generics sustainability issues, Generics 180-day exclusivity period and Generics supply chain security issues; Biosimilars sustainability issues; Biosimilars interchangeability legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEEMIN PASHA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.